Thursday, July 7, 2016

HIV study confirms clinically viable vaccine paving the way for future treatments

In the study, researchers worked with a species of Old World monkeys, rhesus macaques to reproduce the trial results of RV144, the only HIV vaccine that has been tested and shown to reduce the rate of HIV acquisition in a phase III clinical trial.

No comments:

Post a Comment